2 Plasminogen activators and plasminogen activator inhibitors: biochemical aspects
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abercrombie, 1990, Fibrin specific thrombolysis by two-chain urokinase-type plasminogen activator cleaved after Arginine 156 by thrombin, Thrombosis and Haemostasis, 64, 426, 10.1055/s-0038-1647331
Adams, 1991, A synthetic DNA encoding a modified human urokinase resistant to inhibition by serum plasminogen activator inhibitor, The Journal of Biological Chemistry, 266, 8476, 10.1016/S0021-9258(18)92999-6
Bakker, 1993, Introduction of lysine and clot binding properties in the kringle one domain of tissue-type plasminogen activator, The Journal of Biological Chemistry, 268, 18496, 10.1016/S0021-9258(17)46654-3
Barlati, 1991, Tyrosine phosphorylation of human urokinase-type plasminogen activator, FEBS Letters, 281, 137, 10.1016/0014-5793(91)80377-F
Beebe, 1989, A linear amino acid sequence involved in the interaction of t-PA with its endothelial cell receptor, Blood, 74, 2034, 10.1182/blood.V74.6.2034.2034
Delin, 1993, Biology and facultative secretion of plasminogen activator inhibitor-2, Thrombosis and Haemostasis, 70, 144, 10.1055/s-0038-1646176
Bennett, 1991, High resolution analysis of functional determinants on human tissue-type plasminogen activator, The Journal of Biological Chemistry, 266, 5191, 10.1016/S0021-9258(19)67773-2
Bergum, 1992, Vampire bat salivary plasminogen activator exhibits a strict and fastidious requirement for polymeric fibrin as its cofactor, unlike human tissue-type plasminogen activator. A kinetic analysis, The Journal of Biological Chemistry, 267, 17726, 10.1016/S0021-9258(19)37103-0
Binnema, 1986, Quantitation of urokinase antigen in plasma and culture media by use of an ELISA, Thrombosis Research, 43, 569, 10.1016/0049-3848(86)90077-0
Binnema, 1990, The contact-system dependent plasminogen activator from human plasma: identification and characterization, Thrombosis and Haemostasis, 64, 390, 10.1055/s-0038-1647325
Björquist, 1994, PAI-1 binds exclusively to the protease domain of t-PA, Fibrinolysis, 8, 18, 10.1016/0268-9499(94)90335-2
Booth, 1988, A plasminogen activator inhibitor (PAI-2) circulates in two molecular forms during pregnancy, Thrombosis and Haemostasis, 59, 77, 10.1055/s-0038-1642569
Brakman, 1966, A group of patients with impaired plasma fibrinolytic system and selective inhibition of tissue activator-induced fibrinolysis, Scandinavian Journal of Haematology, 3, 389, 10.1111/j.1600-0609.1966.tb02382.x
Bu, 1994, Cellular receptors for the plasminogen activators, Blood, 83, 3427, 10.1182/blood.V83.12.3427.3427
Buko, 1991, Characterization of a posttranslational fucosylation in the growth factor domain of urinary plasminogen activator, 88, 3992
Carmeliet, 1994, Evaluation of the plasminogen/plasmin system in transgenic mice, Fibrinolysis, 8, 269, 10.1016/0268-9499(94)90725-0
Carrell, 1991, Mobile reactive centre of serpins and the control of thrombosis, Nature, 353, 576, 10.1038/353576a0
Chan, 1991, A novel sialylated N-acetylgalactosamine-containing oligosaccharide is the major complex-type structure present in Bowes melanoma tissue plasminogen activator, Glycobiology, 1, 173, 10.1093/glycob/1.2.173
Cheng, 1992, Binding of tissue plasminogen activator to human endothelial cells. Importance of the B-chain as a ligand, Biochemical Journal, 287, 407, 10.1042/bj2870407
Chmielewska, 1988, Kinetics of the inhibition of plasminogen activators by the plasminogen-activator inhibitor. Evidence for ‘second-site’ interactions, Biochemical Journal, 251, 327, 10.1042/bj2510327
Declerck, 1991, Role of α2-antiplasmin in fibrin-specific clot lysis with single-chain urokinase-type plasminogen activator in human plasma, Thrombosis and Haemostasis, 65, 394, 10.1055/s-0038-1648159
Declerck, 1992, Identification of a conformationally distinct form of plasminogen activator inhibitor-1, acting as a non-inhibitory substrate for tissue-type plasminogen activator, The Journal of Biological Chemistry, 267, 11693, 10.1016/S0021-9258(19)49751-2
Danø, 1985, Plasminogen activators, tissue degradation, and cancer, Advances in Cancer Research, 44, 139, 10.1016/S0065-230X(08)60028-7
De Munk, 1990, Fibrinolytic properties of single chain urokinase-type plasminogen activator (pro-urokinase), Fibrinolysis, 4, 1, 10.1016/S0268-9499(05)80034-7
De Munk, 1991, Acceleration of the thrombin inactivation of single chain urokinase-type plasminogen activator (pro-urokinase) by thrombomodulin, Journal of Clinical Investigation, 88, 1680, 10.1172/JCI115483
De Munk, 1993, Comparison of the in vitro fibrinolytic activities of low and high molecular weight single-chain urokinase-type plasminogen activator, Thrombosis and Haemostasis, 70, 481, 10.1055/s-0038-1649609
De Munk, 1993, Role of the glycosaminoglycan component of thrombomodulin in its acceleration of the inactivation of single-chain urokinase-type plasminogen activator by thrombin, Biochemical Journal, 290, 655, 10.1042/bj2900655
De Munk, 1994, Urokinase and its complex with plasminogen activator inhibitor-3/protein C inhibitor in urine, Fibrinolysis, 8, 9, 10.1016/0268-9499(94)90026-4
Downing, 1992, Solution structure of the fibrin binding finger domain of tissue-type plasminogen activator determined by 1H nuclear magnetic resonance, Journal of Molecular Biology, 225, 821, 10.1016/0022-2836(92)90403-7
Drag, 1994, Activation of pro-urokinase by cathepsin G in the presence of glucosaminoglycans, Fibrinolysis, 8, 192, 10.1016/S0268-9499(05)80019-0
Edelberg, 1991, The inhibition of tissue type plasminogen activator by plasminogen activator inhibitor-1, The Journal of Biological Chemistry, 266, 7488, 10.1016/S0021-9258(20)89472-1
Ehrlich, 1990, Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties, The Journal of Biological Chemistry, 265, 13029, 10.1016/S0021-9258(19)38262-6
Felez, 1993, Competition between plasminogen and tissue plasminogen activator for cellular binding sites, Blood, 82, 2433, 10.1182/blood.V82.8.2433.2433
Fleury, 1993, Mechanism of the enhanced intrinsic activity of single-chain urokinase-type plasminogen activator during ongoing fibrinolysis, The Journal of Biological Chemistry, 268, 18554, 10.1016/S0021-9258(17)46663-4
Franco, 1992, Separation and characterization of non-phosphorylated and serine-phosphorylated urokinase. Catalytic properties and sensitivity to plasminogen activator inhibitor type 1, The Journal of Biological Chemistry, 267, 19369, 10.1016/S0021-9258(18)41784-X
Hajjar, 1994, α-Fucose-mediated binding and degradation of tissue-type plasminogen activator by HepG2 cells, Journal of Clinical Investigation, 93, 703, 10.1172/JCI117023
Hajjar, 1994, An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II, The Journal of Biological Chemistry, 269, 21191, 10.1016/S0021-9258(17)31947-6
Harris, 1991, Tissue plasminogen activator has an O-linked fucose attached to threonine-61 in the epidermal growth factor domain, Biochemistry, 30, 2311, 10.1021/bi00223a004
Higgins, 1990, Tissue plasminogen activator: the biochemistry and pharmacology of variants produced by mutagenesis, Annual Reviews of Pharmacology and Toxicology, 30, 91, 10.1146/annurev.pa.30.040190.000515
Higgins, 1992, A zymogenic tissue plasminogen activator variant: the Phe 305 → His mutation suppresses fibrin(ogen) stimulated plasminogen activation by one chain t-PA, Fibrinolysis, 6, 161, 10.1016/0268-9499(92)90055-M
Holmes, 1985, Cloning and expression of the gene for pro-urokinase in Escherichia coli, Bio/Technology, 3, 923, 10.1038/nbt1085-923
Horrevoets, 1994, The specific roles of finger and kringle 2 domains of tissue-type plasminogen activator during in vitro fibrinolysis, The Journal of Biological Chemistry, 269, 12639, 10.1016/S0021-9258(18)99924-2
Horrevoets, 1993, Thrombin-variable region 1 (VR1), The Journal of Biological Chemistry, 268, 779, 10.1016/S0021-9258(18)54001-1
Hoylaerts, 1982, Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin, The Journal of Biological Chemistry, 257, 2912, 10.1016/S0021-9258(19)81051-7
Husain, 1991, Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities, Biochemistry, 30, 5797, 10.1021/bi00237a024
Husain, 1993, Fibrin affinity of urokinase-type plasminogen activator. Evidence that Zn2+ mediates strong and specific interaction of single-chain urokinase with fibrin, The Journal of Biological Chemistry, 268, 8574, 10.1016/S0021-9258(18)52914-8
Kaczmarek, 1993, Initial interaction between fibrin and tissue plasminogen activator (t-PA). The Gly-Pro-Arg-Pro binding site on fibrin(ogen) is important for t-PA activity, The Journal of Biological Chemistry, 268, 2474, 10.1016/S0021-9258(18)53800-X
Kaneko, 1992, Interactions between the finger and kringle-2 domains of tissue-type plasminogen activator and plasminogen activator inhibitor-1, Journal of Biochemistry, 111, 244, 10.1093/oxfordjournals.jbchem.a123744
Keijer, 1991, On the target specificity of plasminogen activator inhibitor 1: the role of heparin, vitronectin, and the reactive site, Blood, 78, 1254, 10.1182/blood.V78.5.1254.1254
Keyt, 1994, A faster-acting and more potent form of tissue plasminogen activator, 91, 3670
Kentzer, 1990, Carbohydrate composition and presence of a fucose-protein linkage in recombinant human pro-urokinase, Biochemical and Biophysical Research Communications, 171, 401, 10.1016/0006-291X(90)91407-J
Kounnas, 1993, Low density lipoprotein receptor-related protein/α2-macroglobulin receptor mediates cellular uptake of pro-urokinase, The Journal of Biological Chemistry, 268, 21862, 10.1016/S0021-9258(20)80620-6
Kristensen, 1987, Tissue-type plasminogen activator in somatostatin cells of rat pancreas and hypothalamus, Endocrinology, 88, 2238, 10.1210/endo-121-6-2238
Kruithof, 1988, Inhibitors of plasminogen activators, 189
Kruithof, 1988, Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states, Thrombosis and Haemostasis, 59, 7, 10.1055/s-0038-1642556
Kuiper, 1992, In vivo and in vitro interaction of high and low molecular weight single-chain urokinase-type plasminogen activator with rat liver cells, The Journal of Biological Chemistry, 267, 1589, 10.1016/S0021-9258(18)45986-8
Lenich, 1992, The influence of glycosylation on the catalytic and fibrinolytic properties of pro-urokinase, Thrombosis and Haemostasis, 68, 539, 10.1055/s-0038-1646314
Li, 1992, Biochemical and biologic properties of rt-PA del(K296-G302), a recombinant human tissue-type plasminogen activator deletion mutant resistant to plasminogen activator inhibitor-1, Blood, 79, 417, 10.1182/blood.V79.2.417.417
Lijnen, 1990, Plasminogen activation with single-chain urokinase-type plasminogen activator (scu-PA). Studies with active site mutagenized plasminogen (Ser740 → Ala) and plasmin-resistant scu-PA (Lys158 → Glu), The Journal of Biological Chemistry, 265, 5232, 10.1016/S0021-9258(19)34111-0
Liu, 1991, A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin, Journal of Clinical Investigation, 88, 2012, 10.1172/JCI115528
Liu, 1992, Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UK, Biochemistry, 31, 6311, 10.1021/bi00142a021
Liu, 1993, The kinetics of plasminogen activation by thrombin-cleaved pro-urokinase and promotion of its activity by fibrin fragment E-2 and by tissue plasminogen activator, Blood, 81, 980, 10.1182/blood.V81.4.980.980
Liu, 1992, A transitional state of pro-urokinase that has a higher catalytic efficiency against Glu-plasminogen than urokinase, The Journal of Biological Chemistry, 267, 15289, 10.1016/S0021-9258(19)49532-X
Longstaff, 1992, Kinetics of plasmin activation of single chain urinary-type plasminogen activator (scu-PA) and demonstration of a high affinity interaction between scu-PA and plasminogen, The Journal of Biological Chemistry, 267, 173, 10.1016/S0021-9258(18)48475-X
Madison, 1994, Probing structure-function relationships of tissue-type plasminogen activator by site-specific mutagenesis, Fibrinolysis, 8, 221, 10.1016/0268-9499(94)90720-X
Madison, 1990, Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1, 87, 3530
Madison, 1990, Restoration of serine protease inhibitor interaction by protein engineering, The Journal of Biological Chemistry, 265, 21423, 10.1016/S0021-9258(18)45753-5
Madison, 1993, Converting tissue plasminogen activator to a zymogen: a regulatory triad of Asp-His-Ser, Science, 262, 419, 10.1126/science.8211162
Mangel, 1991, Conformation of one- and two-chain high molecular weight urokinase analyzed by small-angle neutron scattering and vacuum ultraviolet circular dichroism, The Journal of Biological Chemistry, 266, 9408, 10.1016/S0021-9258(18)92834-6
Marcotte, 1993, Characterization of the activation of pro-urokinase by thermolysin, Biochimica et Biophysica Acta, 1160, 105, 10.1016/0167-4838(93)90203-4
Marcotte, 1992, A-chain isozymes of recombinant and natural urokinases: preparation, characterization, and their biochemical and fibrinolytic properties, Fibrinolysis, 6, 69, 10.1016/0268-9499(92)90063-N
Marcotte, 1992, The matrix metalloproteinase Pump-1 catalyzes formation of low molecular weight (pro)urokinase in cultures of normal human kidney cells, The Journal of Biological Chemistry, 267, 13803, 10.1016/S0021-9258(19)49637-3
Margossian, 1993, Physical characterization of recombinant tissue plasminogen activator, Biochimica et Biophysica Acta, 1163, 250, 10.1016/0167-4838(93)90159-O
Masson, 1988, Kinetic analysis of the interaction between plasminogen activator inhibitor-1 and tissue-type plasminogen activator, Biochemical Journal, 256, 237, 10.1042/bj2560237
Mastronicola, 1990, Serine phosphorylation of biosynthetic pro-urokinase from human tumor cells, FEBS Letters, 266, 109, 10.1016/0014-5793(90)81519-T
Mottonen, 1992, Structural basis of latency in plasminogen activator inhibitor-1, Nature, 355, 270, 10.1038/355270a0
Naski, 1993, Kinetics of inactivation of α-thrombin by plasminogen activator inhibitor-1, The Journal of Biological Chemistry, 268, 12367, 10.1016/S0021-9258(18)31399-1
Nauland, 1994, Activation of thrombin-inactivated single-chain urokinase-type plasminogen activator by dipeptidyl peptidase I (cathepsin C), European Journal of Biochemistry, 223, 497, 10.1111/j.1432-1033.1994.tb19018.x
Nesheim, 1990, The dissociation constants and stoichiometries of the interactions of Lys-plasminogen and chloromethyl ketone derivatives of tissue plasminogen activator and the variant ΔFEIX with intact fibrin, The Journal of Biological Chemistry, 265, 21541, 10.1016/S0021-9258(18)45774-2
Nienaber, 1992, Conformational similarities between one-chain and two-chain tissue plasminogen activator (t-PA): implications to the activation mechanism on one-chain t-PA, Biochemistry, 31, 3852, 10.1021/bi00130a017
Novokhatny, 1991, Domain structure and domain-domain interactions of recombinant tissue plasminogen activator, The Journal of Biological Chemistry, 266, 12994, 10.1016/S0021-9258(18)98794-6
Novokhatny, 1992, Domain structure and interactions of recombinant urokinase-type plasminogen activator, The Journal of Biological Chemistry, 267, 3878, 10.1016/S0021-9258(19)50608-1
Nowak, 1993, NMR studies of the dynamics of the multidomain protein urokinase-type plasminogen activator, Biochemistry, 32, 298, 10.1021/bi00052a038
Ny, 1984, The structure of the human tissue-type plasminogen activator gene: correlation of intron and exon structures to functional and structural domains, 81, 5355
Nykj˦r, 1992, Purified α2-macroglobulin receptor/LDL receptor-related protein binds urokinase plasminogen activator inhibitor type-1 complex. Evidence that the α2-macroglobulin receptor mediates cellular degradation or urokinase receptor-bound complexes, The Journal of Biological Chemistry, 267, 14543, 10.1016/S0021-9258(18)42072-8
Orth, 1994, Low density lipoprotein receptor-related protein is necessary for the internalization of both tissue-type plasminogen activator-inhibitor complexes and free tissue-type plasminogen activator, The Journal of Biological Chemistry, 269, 21117, 10.1016/S0021-9258(17)31937-3
Otter, 1991, Binding of tissue-type plasminogen activator by the mannose receptor, The Journal of Biological Chemistry, 266, 13931, 10.1016/S0021-9258(18)92791-2
Otter, 1992, Mechanisms of tissue-type plasminogen activator (tPA) clearance by the liver, 431
Pannell, 1988, Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained, Journal of Clinical Investigation, 81, 853, 10.1172/JCI113394
Parekh, 1989, N-Glycosylation and in vitro enzymatic activity of human recombinant tissue plasminogen activator expressed in chinese hamster ovary cells and a murine cell line, Biochemistry, 28, 7670, 10.1021/bi00445a023
Pennica, 1983, Cloning and expression of human tissue-type plasminogen activator cDNA in E.coli., Nature, 301, 214, 10.1038/301214a0
Petersen, 1990, Quenching of the amidolytic activity of one-chain tissue-type plasminogen activator by mutation of lysine-416, Biochemistry, 29, 3451, 10.1021/bi00466a005
Pfeiffer, 1992, Structure elucidation of sulphated oligosaccharides from recombinant human tissue plasminogen activator expressed in mouse epithelial cells, Glycobiology, 2, 411, 10.1093/glycob/2.5.411
Pohl, 1987, Isolation and characterization of three different carbohydrate chains from melanoma tissue plasminogen activator, European Journal of Biochemistry, 170, 69, 10.1111/j.1432-1033.1987.tb13668.x
Rabbani, 1992, Structural requirements for the growth factor activity of the amino-terminal domain of urokinase, The Journal of Biological Chemistry, 267, 14151, 10.1016/S0021-9258(19)49691-9
Reilly, 1992, Plasminogen activator inhibitor-1 binds to fibrin and inhibits-tissue-type plasminogen activator-mediated dissolution, The Journal of Biological Chemistry, 267, 17128, 10.1016/S0021-9258(18)41903-5
Reilly, 1994, Recombinant plasminogen activator inhibitor type 1: a review of structural, functional, and biological aspects, Blood Coagulation and Fibrinolysis, 5, 73, 10.1097/00001721-199402000-00011
Rijken, 1988, Structure/function relationships of t-PA, Vol 1, 101
Rijken, 1981, Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture, The Journal of Biological Chemistry, 256, 7035, 10.1016/S0021-9258(19)69095-2
Rijken, 1986, Isolation and functional characterization of the heavy and light chains of human tissue-type plasminogen activator, The Journal of Biological Chemistry, 261, 3098, 10.1016/S0021-9258(17)35752-6
Rijken, 1991, Substrate specificity of tissue-type and urokinase-type plasminogen activators, Biochemical and Biophysical Research Communications, 174, 432, 10.1016/0006-291X(91)91434-E
Rijken, 1982, Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator, The Journal of Biological Chemistry, 257, 2920, 10.1016/S0021-9258(19)81052-9
Rijken, 1994, In vitro stability of a tissue-type plasminogen activator mutant, BM 06.022, in human plasma, Thrombosis and Haemostasis, 72, 906, 10.1055/s-0038-1648982
Rijken, 1988, α2-Antiplasmin Enschede is not an inhibitor, but a substrate, of plasmin, Biochemical Journal, 255, 609
Sakharov, 1994, Superficial accumulation of plasminogen during clot lysis (abstract), Fibrinolysis, 8, 83, 10.1016/0268-9499(94)90513-4
Schmitt, 1999, Tumor-associated proteases, Fibrinolysis, 6, 3
Seiffert, 1991, Kinetic analysis of the interaction between type 1 plasminogen activator inhibitor and vitronectin and evidence that the bovine inhibitor binds to a thrombinderived amino-terminal fragment of bovine vitronectin, Biochimica et Biophysica Acta, 1078, 23, 10.1016/0167-4838(91)90087-G
De Serrano, 1993, Specific anionic residues of the recombinant kringle 2 domain of tissue-type plasminogen activator that are responsible for stabilization of its interaction with ω-amino acid ligands, Biochemistry, 32, 3540, 10.1021/bi00065a004
Spellman, 1989, Carbohydrate structures of human tissue plasminogen activator expressed in chinese hamster ovary cells, The Journal of Biological Chemistry, 264, 14100, 10.1016/S0021-9258(18)71649-9
Stack, 1994, Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase), The Journal of Biological Chemistry, 269, 9416, 10.1016/S0021-9258(17)36896-5
Strandberg, 1991, The oxidative inactivation of plasminogen activator inhibitor type 1 results from a conformational change in the molecule and does not require the involvement of the P′1 methionine, The Journal of Biological Chemistry, 266, 13852, 10.1016/S0021-9258(18)92780-8
Suenson, 1990, The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation, The Journal of Biological Chemistry, 265, 22228, 10.1016/S0021-9258(18)45694-3
Thorsen, 1992, The mechanism of plasminogen activation and the variability of the fibrin effector during tissue-type plasminogen activator-mediated fibrinolysis, Vol. 667, 52
Thorsen, 1988, Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2, European Journal of Biochemistry, 175, 33, 10.1111/j.1432-1033.1988.tb14162.x
Tsuji, 1990, Specificity of human natural antibody to recombinant tissue-type plasminogen activator (t-PA) expressed in mouse C127 cells, Chemical and Pharmacological Bulletin, 38, 765, 10.1248/cpb.38.765
Van Mourik, 1984, Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells, The Journal of Biological Chemistry, 259, 14914, 10.1016/S0021-9258(17)42691-3
Van Zonneveld, 1986, Autonomous functions of structural domains on human tissue-type plasminogen activator, 83, 4670
Vaughan, 1990, Studies of recombinant plasminogen activator inhibitor-1 in rabbits, Circulation Research, 67, 1281, 10.1161/01.RES.67.5.1281
Verheijen, 1986, Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin, The EMBO Journal, 5, 3525, 10.1002/j.1460-2075.1986.tb04678.x
Von Heijne, 1991, The efficiency of the uncleaved secretion signal in the plasminogen activator inhibitor type 2 protein can be enhanced by point mutations that increase its hydrophobicity, The Journal of Biological Chemistry, 266, 15240, 10.1016/S0021-9258(18)98608-4
De Vos, 1992, Crystal structure of the kringle 2 domain of tissue plasminogen activator at 2.4-A resolution, Biochemistry, 31, 270, 10.1021/bi00116a037
Wagner, 1989, Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA), Journal of Clinical Investigation, 84, 647, 10.1172/JCI114211
Wallén, 1982, Purification and identification of two structural variants of porcine tissue plasminogen activator by affinity adsorption on fibrin, Biochimica et Biophysica Acta, 719, 318, 10.1016/0304-4165(82)90105-2
Warshawsky, 1993, 39-kD protein inhibits tissue-type plasminogen activator clearance in vivo, Journal of Clinical Investigation, 92, 937, 10.1172/JCI116669
Weening-Verhoeff, 1990, Involvement of aspartic and glutamic residues in kringle-2 of tissue-type plasminogen activator in lysine binding, fibrin binding and stimulation of activity as revealed by chemical modification and oligonucleotide-directed mutagenesis, Protein Engineering, 4, 191, 10.1093/protein/4.2.191